|
HGSC |
CCC |
EC |
MC |
LGSC |
Precursor lesions |
Serous tubal intraepithelial carcinoma |
Endometriosis |
Endometriosis |
Unknown |
Serous borderline tumor |
Molecular genetics |
P53, BRCA1, BRCA2. HRD with genomic instability |
PI3K, ARID1A, MSI |
PTEN, βcatenin, ARID1A, MSI |
KRAS, HER2 |
BRAF, KRAS, NRAS |
Potential targets |
PARPi, Angiogenesis |
Angiogenesis
PI3K |
Hormone receptors, mTOR |
HER2/neu |
BRAF, MEK |
HRD-homologous recombination deficiencies (NF1, RB1, CDK12) |